Search Results

< Back Go back A Bit About Srivatsa Aithal, PhD Director of R&D Sri Aithal pursued his Post-Doc at McMaster University and Ph.D. at Sherbrooke University in Canada. He drove the effort to commercialize impedance spectroscopy-based sensing at Abnova, Taiwan. He was also a Co-Founder of Celerite Labs, a startup company commercializing magnetic bio-printing technology that accelerated drug discovery. Sri has several journal publications and an approved patent. < Previous Next >

Go back Hoa T. Nguyen, PhD Board member Vice President, AMVI Partners, LLC Director of Phu Sa Trading Co;Ltd Mrs Hoa Nguyen is a professional in significant product development, marketing and sales leadership experience in the agricultural industry sector. She has worked for many years with Monsanto and Syngenta. Hoa also the Director of Phu Sa Vegetable Seed and Agricultural Product Trading Co., LTD. With her experienced as a Former Sales and Marketing Director of East West Seed Vietnam Co. and Former SEA Sales Lead of Vegetable Seed Division, Monsanto USA. Previously, Hoa is the Chief of Representative Office in Vietnam for Seminis Vegetable Seed -USA and Product Development Manager of Vegetable Seed Division, Syngenta Vietnam. Previous Next

< Back Go back A Bit About Valerie Maria Tuyen Vo Chief Investment Officer Valerie is a proven leader in capital acquisition and investment strategy, leveraging her extensive network and deep understanding of the Vietnamese American business community. As the founder and former President of the Vietnamese American Business Council (VABC), she cultivated strong relationships with high-net-worth individuals and investors, fostering a robust fundraising platform for innovative ventures. Her passion extends beyond the VABC, actively participating in supporting US and Vietnamese startups, playing a pivotal role in securing funding and guiding them toward product launches. At Hememics, Valerie spearheaded fundraising efforts, securing the vast majority of the company's capital needs. < Previous Next >

Go back Nha Duong Board member Investor Previous Next

< Back Go back A Bit About John L. Warden, Jr. Co-Founder & CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, and HemStation®. < Previous Next >

Go back David Ho, PhD Board member & Founder Founder, President & CSO An acknowledged expert on blood platelets who has been at the forefront of blood research for over a decade. Dr. Ho is well-published and has expanded the understanding of how coagulation protein factor XI interacts with platelets. Inventor of an unique desiccation technique to preserve human cells for extended storage. He has been issued three US patents and numerous scientific awards. Has directed numerous inter-organizational projects with academic, government and industry partners for cellular products in wound dressing, tissue regeneration and transfusable applications. Previous Next

Go back John L. Warden, Jr. Chairman & Co-Founder Co-Founder, CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, HemStation®. Previous Next

All News July 20th, 2023 Global Startup Heat Map: Discover 5 Top Point-of-Care (POC) Diagnostics Solutions Startups Read more June 8th, 2023 Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read more June 8th, 2023 Partnership to Mass-Produce Graphene Biosensors Read more June 7th, 2023 TEDCO Invests SSBCI Funding into Hememics Biotechnologies, Inc. Read more June 1st. 2023 Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA Read more May 30th, 2023 Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously Read more May 26th, 2023 Gaithersburg diagnostic company Hememics Biotechnologies nabs millions ahead of larger funding round Read more May 25th. 2023 Hememics Biotechnologies Closes $2M Seed 2 Round Read more Next >

Go back Mary E. Schmidt, MD Board member President, Schmidt & Libby Health Advisory Group Associate Professor of Clinical Medicine, VCU Dr. Schmidt is the President of Schmidt and Libby Health Advisory Group. She is board-certified in infectious diseases and internal medicine, has a master’s degree in Public Health from John Hopkins Bloomberg School of Public Health, and is an associate professor of Clinical Medicine at Virginia Commonwealth University. She practiced her specialty of infectious diseases for 25 years and has many awards and honors including the Best Physicians in America. In addition, Dr. Schmidt has had several leadership positions. She was Chief of Staff at the Inova Fairfax Medical Campus from 2010 through 2013 where she led the quality and citizenship activities of 2,400 physicians. She was a member of the Command Center at Inova Fairfax Hospital for Disaster and Bioterrorism Events and a member of the Inova Health System Oversight Committee for the roll out of the Epic medical record system. Dr. Schmidt has also held the position of Director of Transplant Infectious Diseases for 6 years at Inova Fairfax Hospital where she focused on the medical care of immunocompromised individuals and excellence in the care of transplant patients. Previous Next

Go back Thomas S. Dann Board member Managing Director, Castlehaven Advisors, LLC Mr. Dann has almost 20 years’ experience in technology investing and company building. He was previously Managing Director of two early stage venture funds, the Maryland Venture Fund and ECentury Capital Partners. He also formerly served as a director of Global Internet Ventures, LLC and as Founder and Managing Director of Castlehaven Advisors, LLC. During his venture career, Mr. Dann served as a director of numerous early stage companies, as well as a Director of the Mid-Atlantic Venture Association. He received a B.A. degree from Stanford University and a Juris Doctorate from American University Law School. Previous Next

A low-cost platform consisting of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors that can be individually programmed to detect molecular, antigen and antibody targets Hem Chip Hem Box Hem Station ® TM TM Read More Read More Read More *Click on pictures to know more* VS PCR test Lateral flow Compare to Hembox TM TM Compare to Hembox We put a whole lab in your hand so you can make decisions when and wherever necessary simplifying workflows with results within 5 minutes

Get in Touch Feel free to reach out to Hememics First Name Email Last Name Phone Number Subject Message By submitting this form, I acknowledge the receipt of the Hememics Privacy Policy Fields marked with an asterisk ( * ) are required. FAQ Send